CAPTRUST Financial Advisors’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$222K Buy
3,074
+69
+2% +$5.35K ﹤0.01% 2878
2026
Q2
$206K Buy
+3,005
New +$171K ﹤0.01% 2865
2026
Q1
– Sell
-1,876
Closed -$244K – 3129
2025
Q4
$244K Buy
+1,876
New +$257K ﹤0.01% 2394
2022
Q3
– Sell
-76
Closed -$3K – 4056
2022
Q2
$3K Sell
76
-60
-44% -$4.07K ﹤0.01% 4354
2022
Q1
$14K Buy
136
+82
+152% +$9.12K ﹤0.01% 3625
2021
Q4
$8K Buy
54
+26
+93% +$5.81K ﹤0.01% 3859
2021
Q3
$7K Buy
28
+23
+460% +$7.9K ﹤0.01% 3823
2021
Q2
$2K Buy
5
+2
+67% +$859 ﹤0.01% 4215
2021
Q1
$1K Buy
+3
New +$1.56K ﹤0.01% 4251

Other funds holding WGS

CAPTRUST Financial Advisors's WGS Position: Q3 2026 in Review

CAPTRUST Financial Advisors increased its GeneDx Holdings (WGS) stake by 2.3% in Q3 2026, buying an estimated $5.35K and bringing the position to 3,074 shares worth $222K. The position accounts for ﹤0.01% of the portfolio, ranked #2878.

CAPTRUST Financial Advisors first reported a position in WGS in Q1 2021 and has held it in 9 quarters since. The position peaked at $244K in Q4 2025. 218 funds tracked by Wall St. Rank hold WGS as of Q3 2026.

  • CAPTRUST Financial Advisors held 3,074 shares of GeneDx Holdings worth $222K as of Q3 2026.
  • CAPTRUST Financial Advisors bought 69 GeneDx Holdings shares in Q3 2026, an estimated $5.35K.
  • GeneDx Holdings made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q3 2026, its #2878 holding.
  • CAPTRUST Financial Advisors first reported a position in GeneDx Holdings in Q1 2021 and has held it in 9 quarters since.
  • CAPTRUST Financial Advisors's GeneDx Holdings position peaked at $244K in Q4 2025.
  • 218 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.